Araştırma Makalesi
BibTex RIS Kaynak Göster

Process According to Date in The World and Turkey During COVID-19 Pandemic and Effects of Measures Taken to Daily COVID-19 Statistics in Turkey

Yıl 2022, Cilt: 44 Sayı: 4, 404 - 411, 31.12.2022
https://doi.org/10.7197/cmj.936049

Öz

Objective: In this study, it was aimed to update the chronology of the pandemic and to examine the effect of important administrative and political decisions, primarily the curfew, on the number of cases and deaths.
Materials and Methods: In this descriptive study, about COVID-19 important developments in Turkey and the world with were given in chronological order. The effect of curfews on the daily number of cases and deaths was calculated. The effect of curfews on the number of daily cases and deaths was calculated. The conformity of the data to the normal distribution was evaluated with the Kolmogorov-Smirnov test. The Mann-Whitney U test was used to evaluate the data that did not fit the normal distribution.
Results: There was a gradual relaxation in the tight measures, especially in May, June, July and August. As the number of cases increased again after September, the same measures were gradually introduced again. While curfews are ineffective on the daily number of cases, they cause a decrease in the number of daily deaths. The low number of deaths and significant differences in the days when the curfews were effective show that the people in this group comply with the curfews.
Conclusions: Humanity and all states must be prepared for new and more destructive epidemics. For a more effective result, curfews, which will be meticulously followed by all societies and implemented in the form of complete closure, will quickly stop the spread of the epidemic.

Kaynakça

  • 1.Bennett J, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier/Saunders, ISBN (Baskı)9996096742, 9781455748013 2014.3904 s.
  • 2. T.C. Sağlık Bakanlığı. COVID-19 Sağlık Çalışanları Rehberi, Genel Bilgiler ve Epidemiyoloji 2020.Güncellenme Tarihi:7 Aralık 2020(T.R. Ministry of Health. COVID-19 Healthcare Professionals Guide, General Information and Epidemiology 2020. Updated: December 7, 2020)
  • 3.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020 727-733
  • 4.China-s-aggressive-measures-have-slowed-coronavirus-they-may-not-work-other-countries. Available from: https://www.sciencemag.org/news/2020/03/ Date of Access: 19.02.2021
  • 5.VanderWeele TJ. Chen Y. Long K. Kim ES. Trudel-Fitzgerald C. Kubzansky LD. Positive Epidemiology? Epidemiology. 2020; (31),2;189-193.(doi:10.1097/ EDE.0000000000001147.)
  • 6.Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020; 323 (14): 1335. doi: 10.1001 / jama.2020.4344
  • 7. Bénassy-Quéré A, Marimon R, Pisani-Ferry J, Reichlin L, Schoenmaker D, Weder B. COVID-19: Europe needs a catastrophe relief plan. Mitigating the COVID Economic Crisis: Act Fast and Do Whatever, Baldwin R, di Mauro BW (ed.). London, UK: CEPR Press; 2020:121-8 Date of Access: 19.02.2021
  • 8. Budak, F , Korkmaz, Ş . (2020). COVID-19 Pandemi Sürecine Yönelik Genel Bir Değerlendirme: Türkiye Örneği . Sosyal Araştırmalar ve Yönetim Dergisi , (1) , 62-79 . DOI: 10.35375/sayod.738657(Budak, F, Korkmaz, Ş. (2020). Covidien-19 ACTION FOR AN OVERALL ASSESSMENT PROCESS: THE CASE OF TURKEY. Journal of Social Research and Management, (1), 62-79. DOI: 10.35375 / sayod.738657)
  • 9. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;Mar 19 doi: 10.1016/S1473-3099(20)30232-2 [Epub ahead of print].
  • 10.COVID-19 Dağcıoglu Furkan B., Keskin A. Pandemisi Sürecinde Türkiye, Avrupa ve Amerika Verilerinin Karşilaştırılması: Kesitsel Bir Çalışma Ankara Med J, 2020;(2):360-369 (doi// 10.5505/amj.2020.02328)( Covidien -19 Dağcıoglu Furkan B., A. Sharp Pandemic process in Turkey, compared to European and American Data: A Cross-Sectional Study Ankara Med J 2020; (2): 360-369 (doi 10.5505 // / amj.2020.02328)
  • 11.Available from: https://www.worldometers.info/coronavirus/country/brazil/Date of access15.02.2021,
  • 12.From confidence to quarantine: how coronavirus swept ItalyAvailable from:https://www.theguardian.com/world/2020/mar/10/from-confidence-to-quarantine-how-coronavirus-swept-italy Date of access15.02.2021,
  • 13.Moatti, J.P.(2020) The French response to COVID-19: intrinsic difficulties at the interface of science, public health, and policy, Lancet, S2468-2667(20)30087-6
  • 14.TheU.K.’sCoronavirus‘HerdImmunity’Debacle Available from: https://www.theatlantic.com/health/archive/2020/03/coronaviruspandemic-herd-immunity-uk-boris-johnson/608065/Date of access15.02.2021,
  • 15.Cumulative number of coronavirus (COVID-19) cases in the Nordic countries Available from: https://www.statista.com/statistics/1102257/cumulative-coronavirus-cases-in-the-nordics/Date of access15.02.2021
  • 16.S. Sabri Atalay, Gürsel Ersan. Treatment of COVID-19. Tepecik Eğit Hast Derg. 2020; 30(2): 126-134 doi:10.5222/terh.2020.48030
  • 17.The Assessment Report on COVID-19 Global Outbreak Turkish Academy of Sciences Publications, TUBA Report No: 39
  • 18.Anderson, R., May, R. Vaccination and herd immunity to infectious diseases. Nature 318, 323–329 (1985). https://doi.org/10.1038/318323a0
  • 19.Domingo E, Perales C. The time for COVID-19 vaccination. J Virol. 2021 Jan 19:JVI.02437-20. doi: 10.1128/JVI.02437-20. Epub ahead of print. PMID: 33468542.
  • 20.Rong L. Xiancai M, Deng J Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques, Cellular & Molecular Immunology Springer Nature (https://doi.org/10.1038/s41423-021-00641-8)
  • 21.Öztek Z. Halk Sağlığı Sözlüğü, T.C. Sağlık Bakanlığı Sağlık Projesi Genel Koordinatörlüğü, Nisan 1998, Ankara (s.109, 389, 449).(Öztek Z. Public Health Dictionary, T.C. Ministry of Health Health Project General Coordinator, April 1998, Ankara (p.109, 389, 449).
  • 22.Laboratory testing strategy recommendations for COVID-19: Interim guidance WHO/2019-nCoV/lab_testing/2020.1
  • 23.Mut ANU, Aydın S, Baysan C, Büyükdemirci E, Bekar T, Çöl M. Yedi Ülkenin COVID-19 Test Sayıları ve Test Yapma Konusundaki Yaklaşımları. ESTÜDAM Halk Sağlığı Dergisi. 2020;5(COVID-19 Özel Sayısı):17-34.(Mut ANU, Aydın S, Baysan C, Büyükdemirci E, Bekar T, Çöl M. Number of COVID-19 Tests and Approaches of Seven Countries on Testing. ESTÜDAM Journal of Public Health 2020; 5 (COVID-19 Special Issue): 17-34.)
  • 24.TTB (2020). Türk Tabipleri Birliği COVID-19 Pandemisi 4. Ay Raporu, Available from: https://www.ttb.org.tr/kollar/COVID19/yayin_goster.php?G uid=97fd9378-c287 Date of access 17.02.2021(TTB (2020). Turkish Medical Association COVID-19 Pandemic 4th Month Report, Available from: https://www.ttb.org.tr/kollar/COVID19/yayin_goster.php?G uid = 97fd9378-c287 Date of access 17.02.2021)
  • 25.Strengthening and adjusting public health measures throughout the COVID-19 transition phases. Policy considerations for the WHO European Region, 24 April 2020 (produced by WHO/Europe) Available from:https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/strengthening-and-adjusting-public-health-measures-throughout-the-covid-19-transition-phases.-policy-considerations-for-the-who-european-region,-24-april-2020-produced-by-who europe Date of access 17.02.2021
  • 26.Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198. PMID: 32217618.
Yıl 2022, Cilt: 44 Sayı: 4, 404 - 411, 31.12.2022
https://doi.org/10.7197/cmj.936049

Öz

Kaynakça

  • 1.Bennett J, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier/Saunders, ISBN (Baskı)9996096742, 9781455748013 2014.3904 s.
  • 2. T.C. Sağlık Bakanlığı. COVID-19 Sağlık Çalışanları Rehberi, Genel Bilgiler ve Epidemiyoloji 2020.Güncellenme Tarihi:7 Aralık 2020(T.R. Ministry of Health. COVID-19 Healthcare Professionals Guide, General Information and Epidemiology 2020. Updated: December 7, 2020)
  • 3.Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020 727-733
  • 4.China-s-aggressive-measures-have-slowed-coronavirus-they-may-not-work-other-countries. Available from: https://www.sciencemag.org/news/2020/03/ Date of Access: 19.02.2021
  • 5.VanderWeele TJ. Chen Y. Long K. Kim ES. Trudel-Fitzgerald C. Kubzansky LD. Positive Epidemiology? Epidemiology. 2020; (31),2;189-193.(doi:10.1097/ EDE.0000000000001147.)
  • 6.Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020; 323 (14): 1335. doi: 10.1001 / jama.2020.4344
  • 7. Bénassy-Quéré A, Marimon R, Pisani-Ferry J, Reichlin L, Schoenmaker D, Weder B. COVID-19: Europe needs a catastrophe relief plan. Mitigating the COVID Economic Crisis: Act Fast and Do Whatever, Baldwin R, di Mauro BW (ed.). London, UK: CEPR Press; 2020:121-8 Date of Access: 19.02.2021
  • 8. Budak, F , Korkmaz, Ş . (2020). COVID-19 Pandemi Sürecine Yönelik Genel Bir Değerlendirme: Türkiye Örneği . Sosyal Araştırmalar ve Yönetim Dergisi , (1) , 62-79 . DOI: 10.35375/sayod.738657(Budak, F, Korkmaz, Ş. (2020). Covidien-19 ACTION FOR AN OVERALL ASSESSMENT PROCESS: THE CASE OF TURKEY. Journal of Social Research and Management, (1), 62-79. DOI: 10.35375 / sayod.738657)
  • 9. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;Mar 19 doi: 10.1016/S1473-3099(20)30232-2 [Epub ahead of print].
  • 10.COVID-19 Dağcıoglu Furkan B., Keskin A. Pandemisi Sürecinde Türkiye, Avrupa ve Amerika Verilerinin Karşilaştırılması: Kesitsel Bir Çalışma Ankara Med J, 2020;(2):360-369 (doi// 10.5505/amj.2020.02328)( Covidien -19 Dağcıoglu Furkan B., A. Sharp Pandemic process in Turkey, compared to European and American Data: A Cross-Sectional Study Ankara Med J 2020; (2): 360-369 (doi 10.5505 // / amj.2020.02328)
  • 11.Available from: https://www.worldometers.info/coronavirus/country/brazil/Date of access15.02.2021,
  • 12.From confidence to quarantine: how coronavirus swept ItalyAvailable from:https://www.theguardian.com/world/2020/mar/10/from-confidence-to-quarantine-how-coronavirus-swept-italy Date of access15.02.2021,
  • 13.Moatti, J.P.(2020) The French response to COVID-19: intrinsic difficulties at the interface of science, public health, and policy, Lancet, S2468-2667(20)30087-6
  • 14.TheU.K.’sCoronavirus‘HerdImmunity’Debacle Available from: https://www.theatlantic.com/health/archive/2020/03/coronaviruspandemic-herd-immunity-uk-boris-johnson/608065/Date of access15.02.2021,
  • 15.Cumulative number of coronavirus (COVID-19) cases in the Nordic countries Available from: https://www.statista.com/statistics/1102257/cumulative-coronavirus-cases-in-the-nordics/Date of access15.02.2021
  • 16.S. Sabri Atalay, Gürsel Ersan. Treatment of COVID-19. Tepecik Eğit Hast Derg. 2020; 30(2): 126-134 doi:10.5222/terh.2020.48030
  • 17.The Assessment Report on COVID-19 Global Outbreak Turkish Academy of Sciences Publications, TUBA Report No: 39
  • 18.Anderson, R., May, R. Vaccination and herd immunity to infectious diseases. Nature 318, 323–329 (1985). https://doi.org/10.1038/318323a0
  • 19.Domingo E, Perales C. The time for COVID-19 vaccination. J Virol. 2021 Jan 19:JVI.02437-20. doi: 10.1128/JVI.02437-20. Epub ahead of print. PMID: 33468542.
  • 20.Rong L. Xiancai M, Deng J Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques, Cellular & Molecular Immunology Springer Nature (https://doi.org/10.1038/s41423-021-00641-8)
  • 21.Öztek Z. Halk Sağlığı Sözlüğü, T.C. Sağlık Bakanlığı Sağlık Projesi Genel Koordinatörlüğü, Nisan 1998, Ankara (s.109, 389, 449).(Öztek Z. Public Health Dictionary, T.C. Ministry of Health Health Project General Coordinator, April 1998, Ankara (p.109, 389, 449).
  • 22.Laboratory testing strategy recommendations for COVID-19: Interim guidance WHO/2019-nCoV/lab_testing/2020.1
  • 23.Mut ANU, Aydın S, Baysan C, Büyükdemirci E, Bekar T, Çöl M. Yedi Ülkenin COVID-19 Test Sayıları ve Test Yapma Konusundaki Yaklaşımları. ESTÜDAM Halk Sağlığı Dergisi. 2020;5(COVID-19 Özel Sayısı):17-34.(Mut ANU, Aydın S, Baysan C, Büyükdemirci E, Bekar T, Çöl M. Number of COVID-19 Tests and Approaches of Seven Countries on Testing. ESTÜDAM Journal of Public Health 2020; 5 (COVID-19 Special Issue): 17-34.)
  • 24.TTB (2020). Türk Tabipleri Birliği COVID-19 Pandemisi 4. Ay Raporu, Available from: https://www.ttb.org.tr/kollar/COVID19/yayin_goster.php?G uid=97fd9378-c287 Date of access 17.02.2021(TTB (2020). Turkish Medical Association COVID-19 Pandemic 4th Month Report, Available from: https://www.ttb.org.tr/kollar/COVID19/yayin_goster.php?G uid = 97fd9378-c287 Date of access 17.02.2021)
  • 25.Strengthening and adjusting public health measures throughout the COVID-19 transition phases. Policy considerations for the WHO European Region, 24 April 2020 (produced by WHO/Europe) Available from:https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/strengthening-and-adjusting-public-health-measures-throughout-the-covid-19-transition-phases.-policy-considerations-for-the-who-european-region,-24-april-2020-produced-by-who europe Date of access 17.02.2021
  • 26.Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020 Mar 26;368:m1198. doi: 10.1136/bmj.m1198. PMID: 32217618.
Toplam 26 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Dahili Tıp Bilimleri Araştırma Yazıları
Yazarlar

Mehmet Emin Özdemir 0000-0001-6043-5063

İrem Akova 0000-0002-2672-8863

Yayımlanma Tarihi 31 Aralık 2022
Kabul Tarihi 28 Aralık 2022
Yayımlandığı Sayı Yıl 2022Cilt: 44 Sayı: 4

Kaynak Göster

AMA Özdemir ME, Akova İ. Process According to Date in The World and Turkey During COVID-19 Pandemic and Effects of Measures Taken to Daily COVID-19 Statistics in Turkey. CMJ. Aralık 2022;44(4):404-411. doi:10.7197/cmj.936049